Encompass Health Corp (EHC) Files 10-K for the Fiscal Year Ended on December 31, 2019

Author's Avatar
Feb 28, 2020
Article's Main Image

Encompass Health Corp (EHC, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. Encompass Health Corp, formerly Healthsouth Corp provides post-acute healthcare services in the US through a network of inpatient rehabilitation hospitals, home health and hospice agencies. It operates Inpatient Rehabilitation and Home Health and Hospice. Encompass Health Corp has a market cap of $7.41 billion; its shares were traded at around $75.12 with a P/E ratio of 20.81 and P/S ratio of 1.65. The dividend yield of Encompass Health Corp stocks is 1.48%. Encompass Health Corp had annual average EBITDA growth of 12.00% over the past ten years. GuruFocus rated Encompass Health Corp the business predictability rank of 4-star. GuruFocus has detected 1 severe warning sign with Encompass Health Corp. .

For the last quarter Encompass Health Corp reported a revenue of $1.2 billion, compared with the revenue of $1.1 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $4.6 billion, an increase of 7.7% from last year. For the complete 30-year financial data, please go here.. For the last five years Encompass Health Corp had an average revenue growth rate of 13.2% a year.

The reported diluted earnings per share was $3.61 for the year, an increase of 23.2% from previous year. Over the last five years Encompass Health Corp had an EPS growth rate of 11% a year. The Encompass Health Corp had a decent operating margin of 15.04%, compared with the operating margin of 14.72% a year before. The 10-year historical median operating margin of Encompass Health Corp is 17.68%. The profitability rank of the company is 9 (out of 10).

At the end of the fiscal year, Encompass Health Corp has the cash and cash equivalents of $94.8 million, compared with $69.2 million in the previous year. The long term debt was $3.3 billion, compared with $2.5 billion in the previous year. The interest coverage to the debt is 4.3. Encompass Health Corp has a financial strength rank of 4 (out of 10).

At the current stock price of $75.12, Encompass Health Corp is traded at 27.8% premium to its historical median P/S valuation band of $58.79. The P/S ratio of the stock is 1.65, while the historical median P/S ratio is 1.27. The intrinsic value of the stock is $41.54 a share, according to GuruFocus DCF Calculator. The stock gained 20.43% during the past 12 months.

For the complete 20-year historical financial data of EHC, click here.